Target intelligence / Profile preview

Helicobacter pylori glycosidase

Molecular classification
Enzyme, Glycoside hydrolase
01

Overview

Helicobacter pylori glycosidase refers to a group of enzymes produced by the bacterium Helicobacter pylori that catalyze the hydrolysis of glycosidic bonds in complex carbohydrates (Source: PubMed, PMID: 15657238). These enzymes, including alpha-L-fucosidases and peptidoglycan hydrolases, are essential for the bacterium's ability to colonize the human gastric mucosa and maintain cell wall integrity (Source: UniProt, P0C680). By cleaving fucose from host Lewis antigens, the bacterium can utilize host sugars as a nutrient source and facilitate adhesion to the stomach lining (Source: Journal of Biological Chemistry, doi:10.1074/jbc.M411143200). In addition, glycosidases involved in peptidoglycan turnover are critical for bacterial growth and division, making them attractive targets for novel antimicrobial therapy (Source: Microbiology, doi:10.1099/mic.0.2006/001859-0). Targeting these enzymes with specific inhibitors, such as iminosugars like deoxyfuconojirimycin, has shown potential in reducing bacterial fitness and virulence in preclinical studies (Source: Bioorganic & Medicinal Chemistry, doi:10.1016/j.bmc.2010.06.098). As antibiotic resistance in H. pylori becomes a global health concern, these glycosidases represent a promising avenue for developing non-traditional treatments that disrupt the pathogen's metabolic and structural stability (Source: World Journal of Gastroenterology, doi:10.3748/wjg.v20.i30.10212).

Other names
Helicobacter pylori glycoside hydrolaseH. pylori carbohydrate-active enzymeHpGHPeptidoglycan glycosidaseAlpha-L-fucosidase (Afc1)
02

Mechanism of action

Competitive inhibition of bacterial glycoside hydrolases, preventing the cleavage of host-derived glycans and disrupting bacterial cell wall remodeling.

03

Biological functions

Carbohydrate metabolismCell wall remodelingHost-pathogen interactionBacterial colonizationNutrient acquisition
04

Disease associations

InfectionGastritisPeptic ulcer diseaseGastric cancer
05

Safety considerations

Potential cross-reactivity with human lysosomal glycosidasesDisruption of commensal gut microbiotaGastrointestinal side effects from off-target enzyme inhibition
06

Interacting drugs

Deoxyfuconojirimycin

2 more in the full profile.

07

Biomarkers

Helicobacter pylori stool antigenUrease breath testGastric biopsy histologyAnti-H. pylori IgG antibodies

Beyond the preview

Go deeper on Helicobacter pylori glycosidase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Helicobacter pylori glycosidase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call